Patents by Inventor Rebecca L. O'Brien

Rebecca L. O'Brien has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20090028849
    Abstract: The present invention provides methods and compositions for inhibition of Airway Hyperresponsiveness (“AHR”) by deleting, inactivating or inhibiting a subset of innate ?? T cells, alone or in conjunction with the inhibition of Natural Killer T (“NKT”) cells. The methods comprise selective leukophoresis to remove the ?? T cells from the individual's blood or administration of an agent that selectively targets and inhibits or inactivates the ?? T cells. The methods of the present invention can be used to treat AHR in a variety of different ailments, including allergen-induced conditions or respiratory conditions and diseases.
    Type: Application
    Filed: July 24, 2008
    Publication date: January 29, 2009
    Inventors: Rebecca L. O'Brien, Willi K. Born, Niyun Jin, Christina L. Roark
  • Publication number: 20080248025
    Abstract: This invention generally relates to methods to treat conditions and diseases associated with interleukin-17 (IL-17) production. The invention also relates to methods of inhibiting ?? T cells, and particularly, a subset of ?? T cells that produce IL-17.
    Type: Application
    Filed: March 21, 2008
    Publication date: October 9, 2008
    Applicant: NATIONAL JEWISH MEDICAL AND RESEARCH CENTER
    Inventors: Christina Roark, Rebecca L. O'Brien, Willi K. Born
  • Publication number: 20030175212
    Abstract: Disclosed is a method of using soluble &ggr;&dgr; T cell receptors to regulate a &ggr;&dgr; T cell-mediated immune response in a mammal.
    Type: Application
    Filed: January 10, 2003
    Publication date: September 18, 2003
    Inventors: Rebecca L. O'Brien, Willi K. Born, Christina L. Roark, M. Kemal Aydintug